Gamble Jones Investment Counsel’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.58M Sell
30,107
-256
-0.8% -$13K 0.12% 90
2022
Q3
$1.43M Sell
30,363
-2,765
-8% -$143K 0.12% 89
2022
Q2
$1.67M Sell
33,128
-31
-0.1% -$1.69K 0.12% 85
2022
Q1
$2.02M Sell
33,159
-854
-3% -$50.9K 0.13% 87
2021
Q4
$2.24M Buy
34,013
+987
+3% +$63.2K 0.13% 84
2021
Q3
$2.07M Sell
33,026
-1,708
-5% -$109K 0.14% 85
2021
Q2
$2.09M Buy
34,734
+534
+2% +$30.9K 0.14% 88
2021
Q1
$1.88M Buy
34,200
+1,800
+6% +$99.8K 0.13% 89
2020
Q4
$1.77M Buy
32,400
+1,212
+4% +$63.4K 0.12% 93
2020
Q3
$1.56M Buy
31,188
+624
+2% +$30.2K 0.11% 94
2020
Q2
$1.35M Buy
30,564
+2,034
+7% +$86.9K 0.11% 94
2020
Q1
$1.07M Buy
+28,530
New +$1.2M 0.1% 101

Other funds holding IHI

Gamble Jones Investment Counsel's IHI Position: Q4 2022 in Review

Gamble Jones Investment Counsel reduced its iShares US Medical Devices ETF (IHI) stake by 0.84% in Q4 2022, selling an estimated $13K and leaving 30,107 shares worth $1.58M. The position accounts for 0.12% of the portfolio, ranked #90.

Gamble Jones Investment Counsel first reported a position in IHI in Q1 2020 and has held it in 12 quarters since. The position peaked at $2.24M in Q4 2021. 577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

  • Gamble Jones Investment Counsel held 30,107 shares of iShares US Medical Devices ETF worth $1.58M as of Q4 2022.
  • Gamble Jones Investment Counsel sold 256 iShares US Medical Devices ETF shares in Q4 2022, an estimated $13K.
  • iShares US Medical Devices ETF made up 0.12% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #90 holding.
  • Gamble Jones Investment Counsel first reported a position in iShares US Medical Devices ETF in Q1 2020 and has held it in 12 quarters since.
  • Gamble Jones Investment Counsel's iShares US Medical Devices ETF position peaked at $2.24M in Q4 2021.
  • 577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.